Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 38 for “"PCV13"”.
-
Defining the paediatric nasopharyngeal microbiota during PCV13 vaccine implementation
… and expands upon this area of work, focusing on PCV13 implementation, which occurred four years after the introduction of PCV7, and its effects on pneumococcal carriage and other species carried in the upper respiratory tract.<br/><br/>Between 2006/07 and 2012/13, PCV13 vaccine serotypes reduced …
-
Pneumococcal carriage and disease during the implementation of PCV13: 2006 to 2016
… of a 13-valent pneumococcal conjugate vaccine (PCV13) allows the impact of the vaccine to be assessed and may provide information with which to inform public health policies.<br/><br/><i>Streptococcus pneumoniae</i> isolated from the nasopharynx of healthy children were collected alongside …
-
INVASIVE PNEUMOCOCCAL DISEASE RISK IN U.S. ADULTS AND IMPLICATIONS FOR FUTURE PNEUMOCOCCAL VACCINE STRATEGY
… Since 13-valent pneumococcal conjugate vaccine (PCV13) was recommended for children (2010) and adults aged ≥65 years (2014), adult pneumococcal vaccine recommendations have been updated multiple times, and the COVID-19 pandemic disrupted IPD trends. Assessment of these interventions by adult …
-
Health and economic impact of the 13-valent pneumococcal conjugate vaccination program in British Columbia, Canada
… the 13-valent pneumococcal conjugate vaccine (PCV13) for children. This thesis evaluated changes in health and economic burden from pneumococcal disease following the PCV13 introduction in the infant immunization program in British Columbia (BC), Canada. METHODS: A literature search and …
-
DIFFERENCES IN PNEUMOCOCCAL ANTIMICROBIAL RESISTANCE PATTERNS BETWEEN VACCINE AND NON-VACCINE SEROTYPES AMONG CHILDREN IN INDIA
… pneumoniae. In India, phased, regional PCV13 introduction began in 2017. Understanding antibiotic susceptibility profiles of prevalent serotypes is important for monitoring potential changes following PCV introduction. Methods: Between October 2020 and November 2022, nasopharyngeal swabs …
-
Pneumococcal vaccination in inflammatory rheumatic disease and in splenectomy patients. From antibody response to memory cells.
… were invited to receive one dose 13-valent PCV (PCV13). Blood was drawn before and 4-6 weeks after PCV13. Serotype-specific antibody responses were determined using a multiplex fluorescent microsphere immunoassay (MFMI). (II and III) Consecutive patients with systemic vasulitis, rheumatoid …
-
Invasive Pneumokokken-Erkrankung im Kindesalter: Herausforderungen in der Ära des 13-valenten Konjugatimpfstoffs
… 13-valenten Pneumokokken-Konjugatimpfstoff (PCV13) ersetzt. In dieser kumulativen Dissertation werden die folgenden Aspekte untersucht: 1.) Inzidenz von IPE in Deutschland bei Kindern mit Grunderkrankungen und Identifikation einer adäquaten Impfstrategie 2.) Vergleich der Impfstoffwirksamkeit …
-
Φορεία πνευμονιόκοκκου στην Κύπρο σε υγιή παιδιά 6 - 36 μηνών
… Among 1105 children enrolled, 393 had received PCV13 and 685 PCV10. The prevailing isolated serotypes were: 23A (14.3%), 15A (8.9%), 6C (8.6%), 23B (7.5%), 19A (5.4%) and 15B (5%). The proportion of non-vaccine serotypes, PCV10 serotypes, PCV13 additional serotypes (3, 6A, 19A) was 76.8%, 2.1% …
-
Effect of pneumococcal conjugate vaccine dosing schedules on invasive pneumococcal disease in children
… pneumococcal conjugate vaccines (PCV7 and PCV13, respectively) have significantly reduced the burden of invasive pneumococcal disease (IPD) in children. This thesis evaluated the effect of different PCV dosing schedules in children under 18 following their introduction in the infant …
-
Αλλαγές και τάσεις διαχρονικά στην επιδημιολογία και αντιμετώπιση των λοιμώξεων του κατώτερου αναπνευστικού συστήματος σε παιδιά στην Κεντρική Ελλάδα
… 13-valent polysaccharide pneumococcal vaccine (PCV13) has markedly reduced the incidence of pneumonia in several countries. Still, the empyema – complicated pneumonia, represents a major burden in the pediatric population. Few studies, mostly conducted within the first 2 years of widespread use …
-
Selection and Evolution of Pneumococci in Response to Conjugate Vaccines
… The 13-valent pneumococcal conjugate vaccine (PCV13) was introduced in the United States in 2010 for the prevention of invasive pneumococcal disease (IPD) and otitis media and was released without efficacy data. In this study we set out to 1) determine potential efficacy for invasive and …
-
Evaluating the impact of pneumococcal conjugate vaccines on childhood disease burden and antibiotic use: evidence from the United Kingdom and Sub-Saharan Africa
… review summarised existing research on PCV13 effectiveness in reducing childhood IPD incidence and all-cause mortality. Three population-based studies were then conducted: (i) an interrupted time series analysis using IQVIA Medical Research Data (IMRD) from 2008–2019 to assess the impact …
-
Early immune priming and activation against Streptococcus pneumoniae from maternal vaccination.
… could be due to vaccines such as Prevnar13 (PCV13) not being administered until the infant is 8 weeks old. Access to vaccination is limited in LMIC and some children might not receive vaccinations. Therefore, in children, there is a window of susceptibility to this infection that could be …
-
Η επίδραση του εμβολιασμού με τα συζευγμένα εμβόλια κατά του πνευμονιόκοκκου στην επιδημιολογία της πνευμονίας που επιπλέκεται με παραπνευμονική συλλογή (που απαιτεί παροχέτευση)
… συζευγμένου πνευμονιοκοκκικού εμβολίου (PCV13) αναμένεται να παρέχει σημαντική προστασία έναντι των ΠΣ. Η παρούσα μελέτη έχει στόχο τη μελέτη της επίδρασης του εμβολιασμού με PCV7 και PCV13 στην επιδημιολογία των ΠΣ στην παιδική ηλικία. Μέθοδος: Πρόκειται για πολυκεντρική μελέτη …
-
The Economic Evaluation of Adult Immunization Programs: The Importance of Local Context and the Example of Pneumococcal Vaccination
… the 13-valent pneumococcal conjugate vaccine (PCV13) for older adults (65+). Streptococcus pneumoniae is a gram-positive bacterium that represents one of the most common causes of community-acquired pneumonia (CAP), imposing a significant health and financial burden across the world. Due to the …
-
Χαρακτηριστικά του Στρεπτοκόκκου της πνευμονίας που αποικίζει τον παιδικό πληθυσμό Λεμεσού και Πάφου σε περίοδο υψηλής εμβολιαστικής κάλυψης με τα εμβόλια PCV10 και PCV13: ορότυποι και αντοχή στα αντιβιοτικά
… Πάφου μετά την ευρεία εφαρμογή του PCV10 και του PCV13. Μέθοδος: Λήφθηκαν 299 δείγματα από τον οπίσθιο ρινοφάρυγγα υγιών παιδιών ηλικίας 6 έως 72 μηνών, το διάστημα Δεκέμβριο 2023 - Μάϊο 2024, τα οποία καλλιεργήθηκαν σε κατάλληλα θρεπτικά υλικά. Στη συνέχεια ελέγχθηκε η ευαισθησία στα αντιβιοτικά …
-
Οροτυπία και ευαισθησία στα αντιβιοτικά στελεχών πνευμονιόκοκκου στο ρινοφάρυγγα υγιών παιδιών προσχολικής ηλικίας στον Έβρο και ανταπόκριση του υπό κυκλοφορίας 13-δύναμου συζευγμένου εμβολίου
… 13-valent pneumococcal conjugate vaccine (PCV13) in this population. Serotyping was performed by the Quellung reaction using the 12 pooled antisera Pneumotest panel and specific factor sera. We also studied the in vitro antimicrobial susceptibilities of the isolated pneumococci to several …
-
Relative importance of S. pneumoniae serotypes causing invasive pneumococcal disease in young children after the introduction of conjugate vaccines
… Results: The introduction of highly valent PCVs (PCV13 and/or PCV10) has resulted in a consistent reduction of IPD incidence among young children. The decreases in the incidence of IPD have been driven by declines of cases due to vaccine-targeted serotypes. Less consistently, there is evidence of …
-
The impact of pneumococcal conjugate vaccines on serotype prevalence, proportion, and antibiotic susceptibility of streptococcus pneumoniae among children 0 to 84 months from 2004 through 2023 at Boston Medical Center
… of pneumococci by serotype grouping [PCV7, PCV13 unique + 6C, PCV20-additional, and nonvaccine serotypes and individual serotypes were analyzed for each study. A composite analysis of the data was created for the 20-year period. Comparing prevalence and proportion of pneumococci by serotype …
-
Μελέτη της επιδημιολογίας και μικροβιολογίας της βακτηριακής οξείας μέσης ωτίτιδας με ωτόρροια στην εποχή των συζευγμένων πνευμονιοκοκκικών εμβολίων σε ένα τριτοβάθμιο παιδιατρικό νοσοκομείο της Αττικής
… εμβόλιο(PCV7) αντικαταστάθηκε από το 13-δύναμο(PCV13). Στόχος της μελέτης είναι η διερεύνηση της επίδρασης του εμβολιασμού στην επιδημιολογία της ΟΜΩΩ στην Αττική. Μέθοδος: Καταγράφηκαν οι καλλιέργειες ωτικού εκκρίματος παιδιών με ΟΜΩΩ στο Νοσοκομείο Παίδων «Π.&Α. Κυριακού» το 2007-2019. …
Page 1 of 2